GLG Partners’s Exelixis EXEL Stock Holding History

GLG Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,780	Closed	-$255K	–	361
2017 Q1	$255K	Buy	+11,780	New	+$240K	0.01%	364
2014 Q2	–	Sell	-285,621	Closed	-$1.01M	–	390
2014 Q1	$1.01M	Buy	+285,621	New	+$1.94M	0.02%	302

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

GLG Partners's EXEL Position: Q2 2017 in Review

GLG Partners sold out of Exelixis (EXEL) in Q2 2017, closing a stake of 11,780 shares — an estimated $255K sold.

GLG Partners first reported a position in EXEL in Q1 2014 and held it in 2 quarters. The position peaked at $1.01M in Q1 2014. 249 funds tracked by Wall St. Rank hold EXEL as of Q2 2017.

GLG Partners reported no remaining Exelixis position as of Q2 2017 after selling out during the quarter.
GLG Partners sold 11,780 Exelixis shares in Q2 2017, an estimated $255K.
GLG Partners first reported a position in Exelixis in Q1 2014 and held it in 2 quarters.
GLG Partners's Exelixis position peaked at $1.01M in Q1 2014.
249 funds tracked by Wall St. Rank held Exelixis as of Q2 2017.

Based on GLG Partners's 13F filing for Q2 2017, filed 14 Aug 2017.